Skip to content

Adela, Inc. vs Freenome

Adela, Inc. logo

Adela, Inc.

Advancing the field of epigenomics to transform how cancer is detected and monitored

70 employees · est. 2020 · Foster City, United States

VS
Freenome logo

Freenome

Outpacing cancer starts with early detection

403 employees · est. 2014 · Brisbane, United States

Freenome is the older company (2020 vs 2014); Freenome is the larger of the two.

Side-by-Side Comparison

Adela, Inc. Freenome
Founded
2020 2014 older
Headquarters
Foster City, United States Brisbane, United States
Employees
70 403 larger
Industry
Biotechnology, Pharmaceutical Biotechnology, Pharmaceutical
Total Funding
$108.00M $1.14B
Funding Rounds
3 9
Services
Developing best-in-class technology for cancer diagnosis through blood tests, Scalable platform for detecting minimal residual disease, Monitoring response in patients receiving immunotherapy, Screening and early detection of multiple types of cancer Intelligent Screening Platform, Cancer Detection Tests, PREEMPT CRC Study, Blood-Based Diagnostics
Target Customers
Oncologists, Cancer treatment centers, Healthcare providers, Researchers and scientists in oncology, Patients undergoing cancer treatment Healthcare Professionals, Medical Institutions, Patients at Risk for Cancer, Clinical Researchers
Taxonomy
Blood-based DiagnosticsCancer DetectionEarly Disease DetectionMethylation Enrichment TechnologyGenomic AnalysisBiomarker Discovery +9 BiotechEarly Cancer DetectionBlood TestsMultiomicsColorectal CancerAdvanced Adenomas +7
Website
adelabio.com freenome.com
Adela, Inc. logo

About Adela, Inc.

Adela, Inc. is poised to revolutionize cancer care through its transformative blood testing technology. With the compelling slogan, "Imagine a world in which a single blood draw can be used to detect and enable early treatment of many different diseases," Adela is committed to leveraging biology to...

Freenome logo

About Freenome

Freenome, founded in 2014, is a rising star in the biotech sector headquartered in the United States. The company is dedicated to early cancer detection, aiming to empower individuals in the prevention, detection, and treatment of diseases. Their slogan, "Outpacing cancer starts with early detection...

Also comparing in this category

Comparing more than these two?

Get Adela, Inc., Freenome and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Adela, Inc. compare?

A PDF of Adela, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

Adela, Inc. was founded in 2020, based in Foster City, United States, with 70 employees. Adela, Inc. is poised to revolutionize cancer care through its transformative blood testing technology. With the compelling slogan, "Imagine a world in which a single blood draw can be used to detect. Freenome was founded in 2014, based in Brisbane, United States, with 403 employees. Freenome, founded in 2014, is a rising star in the biotech sector headquartered in the United States. The company is dedicated to early cancer detection, aiming to empower individuals in the preventio.
Adela, Inc. has raised $108.00M and Freenome $1.14B.
Both work in Biotechnology and Pharmaceutical.

Compare Adela, Inc. with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Adela, Inc. on 9 Jun 2026, and Freenome on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout